Posts Tagged ‘monitoring’
Thursday, May 20th, 2010
Success for EndoFLIP!
Cropson’s EndoFLIP has had it’s first use in a new weight loss surgery technique, known as gastric imbrications.
The reversible gastric imbrications technique is a unique procedure that needs no device implanted or no tissue removed from the stomach.
The potential for success in the US is quite realistic, given the popularity for weight loss surgery in the US.
“The EndoFLIP device has the avility to change the way we do bariatric surgery all over the world” says Dr Daniel Cottam, “There has been nothing as revolutionary as this device since the lap band”.
Cottam added “I believe in five years we won’t know how we ever did bariatric surgery without it”.
EndoFLIP technology “fills an important need for the gastric imbrications procedure, namely providing visual feedback to the surgeon “, John O Dea, CEO Crospon as said.
Once again, we wish Crospon the very best of luck with their venture in the US.
Watch this space for further EndoFLIP updates!
Tags: bariatric surgery, crospon, diagnosis, EndoFLIP, Endoscopy, gastric band adjustment, gastric band surgery, gastric bands, gastric imbrications, gastroenterology, Medical Device, medical device developer, medical device development, Medical Devices, monitoring, stoma size, therapy, US Market
Posted in Computer Science, Life Sciences, Manufacturing Engineering, Medical Device Manufacture, Medical Science, R&D, Research and Development, science jobs | Comments Off
Wednesday, April 14th, 2010
Gastric -Band Technology
Following FDA approval for their EndoFLIP product, Medical Device developer Crospon has broken into the US market.
Crospon develops medical devices within the area of gastroenterology specifically in monitoring, diagnosis and therapy.
The World Congress of Endoscopic Surgery were presented with pilot clinical trial results for the optimum stoma size for gastric band adjustment.
Following the release in the European market in 2009, EndoFLIP will now be launched in the US market.
“Gastric banding is the fastes-growing class of bariatric surgery in the US, and we believe that EndoFLIP can bring a new science to gastric-band adjustment”, says Larry Fulton, VP Sales for the Americas.
Crospon Principal investigator Dr Robert G Snow also added, “In addition, we look forward to collaborating with a number of new leading bariatric surgery study centres inside and outside of the US as we collectively seek to better define new techniques for best use of the EndoFLIP system for gastric band adjustments”.
Tags: bariatric surgery, crospon, diagnosis, EndoFLIP, Endoscopy, gastric band adjustment, gastric band surgery, gastric bands, gastroenterology, Medical Device, medical device developer, medical device development, Medical Devices, monitoring, stoma size, therapy, US Market
Posted in Diagnostic Medicine, Medical Device Manufacture, Research and Development, science jobs | Comments Off
Friday, March 12th, 2010
Chief Science Officers come from a variety of Science backrounds including Pharmacy
Science Officers Lead The Way in Irelands start up and established Pharmaceutical R&D companies. They provide the scientific backbone of R&D, Regulatory affairs and Pharmacovigilence activity where insight and understanding go hand in hand.
A typical Chief Science Officer will manage and administer the actvities of other medical drug safety officers, science officers and technical personnel involved first hand in project engineering and the management of other scientists who may also be Pharmacists engaged in the introduction of new drugs which will also involve vigilence reporting and monitoring of ADR’s and PSUR’s.
Irish Pharmaceutical enterprises are highly engaged in the latest Pharmaceutical drug research and development and it is through the technical and scientific know how of science officers that Ireland has gained significant FDI (Foreign Direct Investment)
Eight out of ten major internationla biopharma and pharmaceutical multinationals have now sited here in Ireland and this is showing no sign of slowing yet despite the economic downturn.
Tags: ADR's, biopharma, Chief Science Officer, established Pharmaceutical R&D companies, FDI, Irelands start up companies, management, medical drug safety officer, monitoring, my science jobs, Project Engineer, PSUR's, Regulatory Affairs, Science officers, scientific, Scientists, vigilence reporting
Posted in Biotechnology, Life Sciences, R&D | Comments Off
Monday, January 18th, 2010
Science Officer/ Pharmacist at work
Drug Safety Officer or Chief Science Officer personnel work within pharmacovigilence and are responsible for the monitoring of developed and post marketed products.The role can involve writing of periodic safety update reports (PSUR) and also ensuring the accuracy of these reports written by colleagues in the same department.
PSUR’s are sometimes issued not only internally but for general distribution to offices internationally and these updates are tracked on Databases allowing for close monitoring of Adverse Event Reports (AER’s) to a wider technical community to enhance the safety awareness of drugs in use in the pharmacist community here and abroad.
Drug Safety Officers are usually pharmacists with Phamacy degrees who have worked in hospitals in the UK or Ireland for the HSE or NHS. The current demand for Drug safety officers is on the increase given wider ranges of products currently being developed for customers worldwide which has led to a corresponding increase in science jobs openings for science and pharma graduates. Given the current employment market it is a healthy option for candidates keen to look for a job less ordinary.
Tags: Adverse Event Reports, AER's, Databases Close monitoring, developed, Drug Safety Officer, drugs, HSE, monitoring, NHS, periodic safety update reports, pharmacist, pharmacovigilence, post marketed products, PSUR, PSUR's, report, safety awareness, writing
Posted in Health and Safety, Medical Science, Uncategorized, science jobs | Comments Off
